Robert Bradway Amgen CEO Rating

Amgen's CEO, Robert Bradway, has 248 employee ratings and a score of 77/100, placing them in the Top 10% of similar size companies on Comparably with 10,000+ Employees and Top 20% of other companies in Los Angeles. When breaking the CEO score down by factors such as department, gender, and ethnicity, we see that females at Amgen rate Robert Bradway higher than males, giving the CEO a score of 69/100.

Last updated months ago.

Where This Score Ranks Amgen's CEO Rating

TOP
10%
In the Top 10% of 1339 Similar Sized Companies on Comparably
TOP
20%
In the Top 20% of 403 Nearby Companies in Los Angeles
4th
4th place versus 5 competitors rated on Comparably

Feb

Mar

Apr

Jun

Aug

A77 / 100

Jan

Amgen CEO Robert Bradway Bio

Mr. Robert A. Bradway, also known as Bob, has been the Chief Executive Officer of Amgen Inc. since May 23, 2012. Mr. Bradway is responsible for the Amgen's global commercial operations, manufacturing operations, information technology, global government affairs and worldwide compliance and business ethics organizations. He served as the President of Amgen Inc. from May 2010 to May 2012. He served as the Chief Operating Officer of Amgen from May 2010 to May 23, 2012. He served as the Chief Financial Officer and Executive Vice President at Amgen Inc. from April 10, 2007 to May 2010. Mr. Bradway joined Amgen in 2006 and served as its Vice President of Operations Strategy. He served as Managing Director in investment banking at Morgan Stanley, where he was responsible for the Morgan Stanley's banking department and corporate finance activities in Europe. He joined Morgan Stanley in New York as a health care industry investment banker in 1985 and moved to London in 1990, where he served as the Head of the Morgan Stanley's international health care investment banking activities. He has been the Chairman of Amgen Inc. since January 1, 2013. He has been an Independent Director of The Boeing Company since October 14, 2016. He has been a Director at Amgen Inc. since October 2011. He serves as a Trustee of University of Southern California. He served as an Independent Director of Norfolk Southern Corporation from July 2011 to May 11, 2017. He served as a Director of Micromet, Inc. from March 2, 2012 to March 7, 2012. He is chairman of the CEO Roundtable on Cancer, a non-profit organization comprised of executives founded to have solutions to cancer treatment and prevention. He holds a B.A in Biology from Amherst College and an MBA from Harvard University.

Who Ranks Amgen's CEO Rating the Highest?

Department - Design 93/100

Department - Business Development 83/100

Department - Engineering 80/100

Who Ranks Amgen's CEO Rating the Lowest?

Ethnicity - Asian or Pacific Islander 52/100

Department - Operations 54/100

Tenure - 1 to 2 Years 55/100

Amgen CEO Robert Bradway At a Glance

The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Amgen.

Based on 248 ratings, Robert Bradway ranks right below Genzyme's CEO, David Meeker.

Amgen's CEO is highly regarded by the Design department, the Business Development department, and the Engineering department. However, Asian or Pacific Islander employees, the Operations department, and employees who have been at the company 1 to 2 Years have a less favorable view of the CEO and believe there is room for improvement. Overall, the CEO score has remained stable over the last 90 days.